Skip to content

Drug interactions

Irinotecan + Teniposide

Severity: Moderate

Irinotecan and Teniposide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents are cytotoxic and cause myelosuppression, so combined use may deepen neutropenia and increase infection risk. Teniposide has been described as a P-glycoprotein substrate or modulator, but a clinically meaningful change in irinotecan exposure is not established.

What this interaction means in plain words

Irinotecan and Teniposide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive myelosuppression; a transporter-mediated pharmacokinetic effect on irinotecan is theoretical.

What to do

Monitor complete blood counts closely, particularly neutrophils, and watch for diarrhea. Reduce doses or delay cycles if severe myelosuppression develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan and Teniposide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan with Teniposide?

MediHelp rates the interaction as moderate. Irinotecan and Teniposide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents are cytotoxic and cause myelosuppression, so combined use may deepen neutropenia and increase infection risk. Teniposide has been described as a P-glycoprotein substrate or modulator, but a clinically meaningful change in irinotecan exposure is not established.

How serious is the interaction between Irinotecan and Teniposide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts closely, particularly neutrophils, and watch for diarrhea. Reduce doses or delay cycles if severe myelosuppression develops.

What other medicines interact with Irinotecan?

MediHelp also lists interactions of Irinotecan with, for example, Clozapine, Sacituzumab govitecan, Adenovirus types 4 and 7 live. The full list is on the Irinotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in